Parkman Healthcare Partners’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-660,000
| Closed | -$1.46M | – | 95 |
|
|
2025
Q1 | $1.46M | Buy |
660,000
+310,000
| +89% | +$685K | 0.17% | 80 |
|
|
2024
Q4 | $1.91M | Buy |
+350,000
| New | +$1.91M | 0.25% | 75 |
|
|
2022
Q2 | – | Sell |
-77,389
| Closed | -$2.73M | – | 84 |
|
|
2022
Q1 | $2.73M | Sell |
77,389
-21,299
| -22% | -$751K | 0.8% | 42 |
|
|
2021
Q4 | $4.14M | Buy |
98,688
+8,688
| +10% | +$364K | 0.91% | 32 |
|
|
2021
Q3 | $4.42M | Hold |
90,000
| – | – | 1.12% | 29 |
|
|
2021
Q2 | $3.76M | Sell |
90,000
-22,500
| -20% | -$939K | 0.82% | 40 |
|
|
2021
Q1 | $4.01M | Buy |
112,500
+2,224
| +2% | +$79.3K | 0.93% | 35 |
|
|
2020
Q4 | $3.09M | Buy |
+110,276
| New | +$3.09M | 0.79% | 50 |
|